title: Highlights of the 83rd European Atherosclerosis Society (EAS) annual Congress, Glasgow 22-25 March, 2015.
authors.affiliation: European Atherosclerosis Society, Mässans gata 18/Box 5243, SE-402 24 Gothenburg, Sweden.
authors.forename: Jane
authors.initials: J
authors.lastname: Stock
mesh_terms: D050197:Atherosclerosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000097:blood; D003245:Consensus Statements as Topic; D005060:Europe; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D017270:Lipoprotein(a) / Q000037:antagonists & inhibitors; D058990:Molecular Targeted Therapy; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D057285:Precision Medicine / Q000379:methods / Q000639:trends; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors; D011877:Radionuclide Imaging; D012307:Risk Factors; D012606:Scotland; D057185:Sedentary Behavior; D012697:Serine Endopeptidases; D012907:Smoking / Q000009:adverse effects; D012955:Societies, Medical
chemical_list: D002317:Cardiovascular Agents; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D017270:Lipoprotein(a); D016376:Oligonucleotides, Antisense; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases